SLC6A3 and Parkinson disease: Next, we evaluated the neuroprotective effect of hCDNF on the nigrostriatal dopaminergic pathway in an MPTP-induced PD model by immunohistochemical staining for the dopaminergic markers TH and DAT (Fig. 3A–D).